Semaglutide sales keep climbing as Ozempic and Wegovy dominate the market. See what drives demand, how pricing works, and how to buy safely in the US.
Semaglutide sales refers to the commercial market for semaglutide, the active ingredient in Ozempic, Wegovy, and Rybelsus, plus the gray-market trade in compounded versions of the drug. Semaglutide is a prescription-only medication in the United States and cannot legally be sold over the counter. Global revenue from semaglutide products has climbed into the tens of billions of dollars per year, making the drug one of the best-selling medicine families in modern pharmaceutical history.
How Big Are Semaglutide Sales Right Now?
Semaglutide is manufactured by Novo Nordisk, and company reports show steep, steady growth since Ozempic launched in 2017. Wegovy followed in 2021, and Rybelsus, the oral form, rounded out the lineup.
| Product | Maker | Main approved use | Reported 2024 global sales (approx.) |
|---|---|---|---|
| Ozempic | Novo Nordisk | Type 2 diabetes | ~$17 billion |
| Wegovy | Novo Nordisk | Chronic weight management | ~$5.5 billion |
| Rybelsus | Novo Nordisk | Type 2 diabetes (oral tablet) | ~$3 billion |
Semaglutide sales are dominated by Ozempic and Wegovy, which together brought in more than $20 billion in reported global revenue in 2024. Analysts expect that figure to keep rising as manufacturing capacity expands and more insurers add coverage.
It is worth separating two different things people mean by the term semaglutide sales. One is the pharmaceutical market, which is the revenue drugmakers report to investors. The other is the consumer market for discounts, coupons, telehealth bundles, and compounded alternatives.
What Is Fueling Demand for Semaglutide?
Several forces pushed semaglutide from a niche diabetes drug into a mainstream product:
- Obesity rates: More than 40% of US adults live with obesity, according to the CDC.
- Clinical results: Trial participants on Wegovy lost roughly 15% of body weight on average.
- Social media: Celebrity and influencer posts turned the drug into a cultural topic.
- Telehealth: Online platforms made it easier to get a prescription without an in-person visit.
- Employer coverage: A growing share of large employers now cover GLP-1 drugs for weight loss.
Demand repeatedly outpaced supply in the early years, which is one reason compounded versions appeared in the first place.
Where Semaglutide Is Legally Sold in the US
Semaglutide cannot be legally sold at a gym, in a grocery aisle, or through a random website that takes a credit card and skips the prescription step.
Legitimate sales channels include:
- Retail and mail-order pharmacies filling a prescription from a licensed clinician.
- Telehealth platforms that connect patients with licensed prescribers and ship from licensed pharmacies.
- Compounding pharmacies operating under state and federal rules, though this channel has narrowed sharply.
Federal regulators have moved to restrict large-scale compounding of semaglutide now that brand-name supply has caught up. Compounded semaglutide is not FDA-approved, and the rules around its sale continue to change.
Semaglutide vs. Tirzepatide and Other Options
Semaglutide is not the only GLP-1 on the market. Eli Lilly's tirzepatide, sold as Mounjaro and Zepbound, works on two hormone pathways instead of one.
| Feature | Semaglutide | Tirzepatide |
|---|---|---|
| Brand names | Ozempic, Wegovy, Rybelsus | Mounjaro, Zepbound |
| Mechanism | GLP-1 receptor agonist | Dual GIP and GLP-1 agonist |
| Average weight loss (trials) | ~15% | ~20–22% |
| Approved uses | Type 2 diabetes, weight management | Type 2 diabetes, weight management, sleep apnea |
| Typical list price | ~$1,000–$1,350 per month | ~$1,050–$1,080 per month |
Tirzepatide produced greater average weight loss than semaglutide in head-to-head trials, which is why so many buyers compare semaglutide vs tirzepatide before choosing a prescription. Both drugs carry similar gastrointestinal side effects and both require a prescription.
Researchers are also testing next-generation combinations such as cagrilintide and semaglutide, which pairs a GLP-1 with an amylin analog. Others explore stacking retatrutide and semaglutide, though that approach is not supported by approved labeling or long-term safety data. None of these investigational options are legally sold as consumer products today.
Pricing, Discounts, and Compounded Versions
In everyday conversation, sales usually means discounts. Here is where legitimate savings actually come from:
- Manufacturer savings cards: Novo Nordisk offers copay assistance for commercially insured patients, which can lower the monthly cost to as little as $25.
- Insurance coverage: Many plans cover Ozempic for diabetes; weight-loss coverage is far more variable.
- Medicare and Medicaid: Medicare generally does not cover semaglutide for weight loss alone.
- Cash-pay programs: Some telehealth providers sell monthly bundles that include the drug, a prescription, and clinical support.
Compounded products sometimes blend semaglutide with other ingredients. You may see listings for semaglutide l carnitine marketed as a weight-loss booster, but these are not FDA-approved and have not been tested in large clinical trials.
Counterfeit and mislabeled semaglutide has been found in the supply chain, including products sold online without a prescription. Treat any no-prescription offer as a red flag.
Safety and What to Know Before You Buy
Semaglutide is effective for many people, but it is not risk-free. Common semaglutide side effects include nausea, vomiting, diarrhea, and constipation, especially during dose increases. Less common but serious risks include pancreatitis, gallbladder disease, and a boxed warning about thyroid C-cell tumors observed in rodents.
Anyone considering semaglutide should consult a licensed healthcare professional about personal risks, dosing, and monitoring. Pregnant or breastfeeding individuals, people with a history of pancreatitis, and those with certain thyroid conditions are usually advised against it.
From a market standpoint, semaglutide sales will likely keep growing as oral formulations, new indications, and combination therapies reach the market. From a consumer standpoint, the safest path remains a legitimate prescription filled by a licensed pharmacy.
RELATED PEPTIDE TOPICSema peptideFrequently Asked Questions
Can you buy semaglutide over the counter in the US?
No. Semaglutide is a prescription-only medication in the United States, and the FDA has not approved any over-the-counter version. Products marketed as OTC semaglutide are usually compounded, mislabeled, or counterfeit.
How much money does semaglutide generate in sales each year?
Novo Nordisk reported roughly $20 billion or more in combined 2024 global sales from Ozempic, Wegovy, and Rybelsus. Ozempic accounts for the majority of that total, while Wegovy is growing the fastest.
Is compounded semaglutide legal to buy?
Compounded semaglutide is legal only in limited circumstances and is not FDA-approved. Federal regulators have moved to stop large-scale compounding now that brand-name supply is available, so many online sellers operate outside the rules.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.